BEIRUT: The French Hospital of the Levant, in collaboration with IRCAD, launched on Wednesday the American fourth-generation robot Da Vinci Xi, known as the world leader in minimally invasive robotic surgery.
The fourth-generation Da Vinci Xi robot is used in gastroenterology, gynecology, urology, otolaryngology (ENT), or cardiothoracic surgeries. The use of these surgical robots will guarantee a rapid and efficient recovery, with lesser risks and minimal scarring.
“Surgery can become autonomous when it's robotic,” noted Prof. Jacques Marescaux, president of IRCAD. “A few years ago, robotics were considered as a gadget. Surgery, in all its specialties combined, will be robotized in the upcoming 10 to 15 years. We must ameliorate robots. This amelioration will enhance surgical performance as well as the surgeon’s control over the surgery.”
Prof. Alexandre de la Taille performed a surgery with the Da Vinci Xi robot in collaboration with Lebanese surgeons. The surgery was broadcasted live in IRCAD France headquarters, Strasbourg, and in the French Hospital of the Levant, Lebanon.
“This robotic/pedagogic platform belongs to all of us, and to our patients specifically,” said Dr. Antoine Maalouf, president of IRCAD Liban. “This acquisition isn’t just that of a man or of a hospital, it is of a country.”
In fact, every 30 seconds, somewhere in the world, a surgeon uses a Da Vinci Surgical System in order to bring a minimally invasive surgery option to a patient.
Robots bring a new era in the minimally invasive surgery: The surgeon no longer physically operates on the patient, but sits in front of a console, with their eyes on the screen providing a 3D visualization through a camera introduced into the human body.
The surgeon is able to go through all organs with a 10 times zoom-in. With handles, he manipulates from afar the robot’s four arms which are introduced in the abdomen. The robot’s four arms rotate up to 360 degrees while the human hand rotates up to 270 degrees only.
“Education and health are the two main links between Lebanon and France,” highlighted Véronique Aulagnon, representing French Ambassador Bruno Foucher.
Prof. Jacques Marescaux founded, in partnership with the medical-surgical industry giants, IRCAD (Research Institute Against Digestive Cancer) in 1994 in Strasbourg, France. The IRCAD institute became the world leader in teaching and training in minimally invasive surgery. It has four international branches, including IRCAD Lebanon, the laparoscopic training center, which was inaugurated in October 2019 and based at the French Hospital of the Levant. IRCAD Lebanon mainly focuses on training surgeons in Lebanon and in the MENA region on the most recent minimally invasive surgery techniques.